4//SEC Filing
Societe des Produits Nestle S.A. 4
Accession 0000899243-20-011298
CIK 0001631650other
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 4:59 PM ET
Size
14.8 KB
Accession
0000899243-20-011298
Insider Transaction Report
Form 4
NESTLE SA
10% Owner
Transactions
- Purchase
Series A Preferred Stock
2020-02-07$319.68/sh+525,634$168,032,049→ 525,634 total(indirect: See Footnote) - Other
Common Stock
2020-04-22$16.11/sh+12,727,113$205,033,790→ 12,727,113 total(indirect: See Footnote) - Purchase
Common Stock
2020-02-07$31.97/sh+1,000,000$31,970,000→ 12,727,113 total(indirect: See Footnote) - Other
Series A Preferred Stock
2020-04-22$161.10/sh+525,634$84,679,637→ 525,634 total(indirect: See Footnote)
Societe des Produits Nestle S.A.
10% Owner
Transactions
- Purchase
Common Stock
2020-02-07$31.97/sh+1,000,000$31,970,000→ 12,727,113 total(indirect: See Footnote) - Other
Common Stock
2020-04-22$16.11/sh+12,727,113$205,033,790→ 12,727,113 total(indirect: See Footnote) - Other
Series A Preferred Stock
2020-04-22$161.10/sh+525,634$84,679,637→ 525,634 total(indirect: See Footnote) - Purchase
Series A Preferred Stock
2020-02-07$319.68/sh+525,634$168,032,049→ 525,634 total(indirect: See Footnote)
Footnotes (3)
- [F1]Consists of 12,727,113 shares of Common Stock held by Nestle Health Science US Holdings, Inc. ("NHS"). NHS is a wholly owned subsidiary of NIMCO US, Inc. ("NIMCO"). NIMCO, in turn, is a wholly-owned subsidiary of Nestle US Holdco, Inc. ("Nestle US Holdco"), which is a wholly-owned subsidiary of Societe des Products Nestle S.A.("SPN"). The ultimate parent company of NHS, NIMCO, Nestle US Holdco and SPN is Nestle S.A. ("Nestle"). Following the purchase referred to in the table above and prior to the internal transfer referred to in Note 3 below, each of these entities may be deemed to share voting and investment power with respect to all shares of Common Stock held by NHS. Each of NIMCO, Nestle US Holdco, SPN and Nestle disclaims beneficial ownership of such shares of Common Stock except to the extent of its pecuniary interest therein.
- [F2]Consists of 525,634 shares of Series A Preferred Stock held by NHS with each share of Series A Preferred Stock convertible into ten shares of Common Stock. Following the purchase and prior to the internal transfer referred to in Note 3 below, each of NHS, NIMCO, Nestle US Holdco, SPN and Nestle may be deemed to share voting and investment power with respect to these shares of Series A Preferred Stock held by NHS. Each of NIMCO, Nestle US Holdco, SPN and Nestle disclaims beneficial ownership of such shares of Series A Preferred Stock except to the extent of its pecuniary interest therein.
- [F3]This transaction constitutes an internal transfer of 12,727,113 shares of Common Stock and 525,634 shares of Series A Preferred Stock from NHS to SPN. Following the transfer, SPN and Nestle may be deemed to share voting and investment power with respect to all shares of Common Stock and Series A Preferred Stock. Nestle disclaims beneficial ownership of such shares of Common Stock and Series A Preferred Stock except to the extent of its pecuniary interest therein. Subsequent to this internal transfer, each of NHS, NIMCO, and Nestle US Holdco no longer hold any shares of Common Stock or Series A Preferred Stock and are therefore no longer Reporting Owners.
Documents
Issuer
Aimmune Therapeutics, Inc.
CIK 0001631650
Entity typeother
IncorporatedSwitzerland
Related Parties
1- filerCIK 0001803539
Filing Metadata
- Form type
- 4
- Filed
- Apr 23, 8:00 PM ET
- Accepted
- Apr 24, 4:59 PM ET
- Size
- 14.8 KB